Morphotek, Inc. | Eisai | United States | federal | 2012 | $141,901 | | federal grant |
Morphotek Inc. | Eisai | Pennsylvania | state | | | $200,000 | loan or bond financing |
Momenta Pharmaceuticals, Inc | Johnson & Johnson | Massachusetts | state | 2012 | $1,224,300 | | tax credit/rebate |
Moderna Therapeutics, Inc. | Moderna Inc. | Massachusetts | state | 2016 | $1,875,000 | | tax credit/rebate |
Moderna Therapeutics, Inc | Moderna Inc. | Massachusetts | state | 2012 | $40,000 | | tax credit/rebate |
Moderna Therapeutics, Inc | Moderna Inc. | Massachusetts | state | 2012 | $98,270 | | tax credit/rebate |
Moderna Therapeutics, Inc | Moderna Inc. | Massachusetts | state | 2013 | $147,996 | | tax credit/rebate |
Moderna Therapeutics, Inc | Moderna Inc. | Massachusetts | state | 2013 | $170,504 | | tax credit/rebate |
Moderna Therapeutics | Moderna Inc. | Massachusetts | state | 2014 | $450,000 | | tax credit/rebate |
Moderna Therapeutics | Moderna Inc. | Massachusetts | state | 2014 | $300,000 | | tax credit/rebate |
MILLIPORE, INC. | Merck KGaA (EMD) | California | state | 2009 | $1,440 | | training reimbursement |
MILLIPORE, INC. | Merck KGaA (EMD) | California | state | 2009 | $143,620 | | training reimbursement |
Millipore, Inc. | Merck KGaA (EMD) | California | state | 2007 | undisclosed | | training reimbursement |
Millipore Corporation | Merck KGaA (EMD) | California | state | 2009 | undisclosed | | training reimbursement |
Millipore Corporation | Merck KGaA (EMD) | New Hampshire | state | 2008 | $43,842 | | training reimbursement |
Millipore Corporation | Merck KGaA (EMD) | Texas | state | 2000 | undisclosed | | property tax abatement |
MILLIPORE CORPORATION | Merck KGaA (EMD) | Missouri | state | 2011 | $397,131 | | tax credit/rebate |
MILLIPORE CORPORATION | Merck KGaA (EMD) | California | state | 2011 | $59,646 | | training reimbursement |
Millipore Corporation | Merck KGaA (EMD) | United States | federal | 2009 | $608,447 | | federal grant |
Merrimack Pharmaceuticals, Inc. | Merrimack Pharmaceuticals | Massachusetts | state | 2015 | $1,350,000 | | tax credit/rebate |
Merrimack Pharmaceuticals, Inc | Merrimack Pharmaceuticals | Massachusetts | state | 2011 | $150,000 | | tax credit/rebate |
Merrimack Pharmaceuticals, Inc | Merrimack Pharmaceuticals | Massachusetts | state | 2011 | $1,196,763 | | tax credit/rebate |
Merrimack Pharmaceuticals, Inc | Merrimack Pharmaceuticals | Massachusetts | state | 2013 | $490,000 | | tax credit/rebate |
Merrimack Pharmaceuticals | Merrimack Pharmaceuticals | Massachusetts | state | 2014 | $633,361 | | tax credit/rebate |
Merck, Sharp & Dohme Corp. | Merck | Pennsylvania | state | 2010 | $1,321,420 | | tax credit/rebate |
Merck, Sharp & Dohme Corp. | Merck | Pennsylvania | state | 2011 | $19,590,893 | | tax credit/rebate |
Merck, Sharp & Dohme Corp. | Merck | Pennsylvania | state | 2012 | $10,263,039 | | tax credit/rebate |
Merck, Sharp & Dohme Corp. | Merck | Pennsylvania | state | 2017 | $506,455 | | tax credit/rebate |
Merck Sharpe & Dohme | Merck | Virginia | state | 2016 | $1,300,000 | | grant |
Merck Sharp & Dohme Corp. II | Merck | North Carolina | state | 2019 | $4,974,750 | | grant |
Merck Sharp & Dohme Corp. | Merck | North Carolina | state | 2004 | $5,514,655 | | grant |
Merck Sharp & Dohme Corp. | Merck | North Carolina | state | 2013 | $1,230,023 | | tax credit/rebate |
Merck Sharp & Dohme Corp. | Merck | North Carolina | state | 2015 | $521,964 | | tax credit/rebate |
Merck Sharp & Dohme Corp. | Merck | North Carolina | state | 2016 | $4,302,041 | | tax credit/rebate |
Merck Sharp & Dohme Corp. | Merck | North Carolina | state | 2015 | $12,098,272 | | tax credit/rebate |
Merck Sharp & Dohme Corp. | Merck | North Carolina | state | 2017 | $2,511,374 | | tax credit/rebate |
Merck Sharp & Dohme Corp. | Merck | North Carolina | state | 2018 | $2,189,941 | | tax credit/rebate |
MERCK SHARP & DOHME CORP | Merck | Pennsylvania | state | 2020 | $1,759,300 | | tax credit/rebate |
Merck Manufacturing (project 6) | Merck | North Carolina | state | 2022 | $167,242 | | training reimbursement |
Merck Animal Health | Merck | Louisiana | state | 2012 | $995,624 | | property tax abatement |
Merck (2015) | Merck | Virginia | state | 2016 | $450,000 | | training reimbursement |
Merck (2015) | Merck | Virginia | state | 2017 | $450,000 | | training reimbursement |
Merck & Co., Inc. | Merck | North Carolina | state | 2008 | $2,940,954 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2008 | $452,785 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2009 | $1,579,355 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2010 | $6,007,498 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2008 | $770,277 | | tax credit/rebate |
Merck & Co., Inc. | Merck | Pennsylvania | state | | $735,000 | | training reimbursement |
Merck & Co., Inc. | Merck | Pennsylvania | state | | $265,000 | | training reimbursement |
Merck & Co., Inc. | Merck | Pennsylvania | state | | $1,200,000 | | grant |
Merck & Co., Inc. | Merck | Pennsylvania | state | 2009 | $1,677,793 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2004 | $24,000,000 | | grant/loan hybrid program |
Merck & Co., Inc. | Merck | Virginia | state | 2010 | $89,383 | | training reimbursement |
Merck & Co., Inc. | Merck | North Carolina | state | 2011 | $55,000 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2011 | $18,000 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2011 | $2,774,342 | | tax credit/rebate |
Merck & Co., Inc. | Merck | New Jersey | state | 1999 | $874,000 | | grant |
Merck & Co., Inc. | Merck | North Carolina | state | 2012 | $130,000 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2012 | $160,804 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2012 | $220,500 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2012 | $6,651,352 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 1999 | $67,000 | | grant |
Merck & Co., Inc. | Merck | North Carolina | state | 2001 | $33,000 | | grant |
Merck & Co., Inc. | Merck | Texas | state | 2017 | $6,000,000 | | grant |
Merck & Co., Inc. | Merck | Virginia | state | 2019 | $7,500,000 | | grant |
Merck & Co. Inc. | Merck | New Jersey | state | 2000 | $3,948,650 | | grant |
Merck & Co | Merck | Virginia | state | 2016 | $1,300,000 | | grant |
Merck | Merck | Virginia | state | 2007 | $1,500,000 | | grant |
Merck | Merck | Virginia | state | 2019 | $1,300,000 | | grant |
Merck | Merck | Virginia | state | 2015 | $1,500,000 | | grant |
Merck | Merck | Virginia | state | 2007 | $500,000 | | grant |
Megadyne Medical Products, Inc. | Johnson & Johnson | United States | federal | 2013 | | $3,375,000 | federal loan or loan guarantee |
Megadyne Medical Products, Inc. | Johnson & Johnson | United States | federal | 2014 | | $3,375,000 | federal loan or loan guarantee |
Megadyne Medical Products, Inc. | Johnson & Johnson | United States | federal | 2015 | | $4,050,000 | federal loan or loan guarantee |
Megadyne Medical Products | Johnson & Johnson | Utah | state | 2009 | $8,538 | | training reimbursement |
Medimmune, LLC | AstraZeneca | Maryland | state | 2010 | $698,034 | | tax credit/rebate |
Medimmune, LLC | AstraZeneca | Maryland | state | 2011 | $462,285 | | tax credit/rebate |
Medimmune, LLC | AstraZeneca | Maryland | state | 2012 | $1,497,096 | | tax credit/rebate |
Medimmune, LLC | AstraZeneca | Maryland | state | 2008 | $611,575 | | tax credit/rebate |
Medimmune, LLC | AstraZeneca | Maryland | state | 2009 | $490,223 | | tax credit/rebate |
Medimmune, LLC | AstraZeneca | Maryland | state | 2014 | $1,497,096 | | tax credit/rebate |
Medimmune, LLC | AstraZeneca | Maryland | state | 2015 | $1,264,635 | | tax credit/rebate |
MedImmune, LLC | AstraZeneca | Maryland | state | 2016 | $1,553,113 | | tax credit/rebate |
MedImmune, LLC | AstraZeneca | Maryland | state | 2017 | $1,939,088 | | tax credit/rebate |
MedImmune, LLC | AstraZeneca | Maryland | state | 2019 | $1,475,043 | | tax credit/rebate |
MedImmune, LLC | AstraZeneca | Maryland | state | 2020 | $791,333 | | tax credit/rebate |
MedImmune, Inc. | AstraZeneca | Maryland | local | | $500,000 | | grant/loan hybrid program |
MedImmune, Inc. | AstraZeneca | Maryland | state | 2004 | $26,775 | | training reimbursement |
Medimmune, Inc. | AstraZeneca | Maryland | state | 2007 | $1,570,977 | | tax credit/rebate |
Medimmune, Inc. | AstraZeneca | Maryland | state | 2005 | $728,623 | | tax credit/rebate |
Medimmune, Inc. | AstraZeneca | Maryland | state | 2004 | $294,900 | | tax credit/rebate |
Medimmune Oncology, Inc. | AstraZeneca | Maryland | state | 2005 | $111,606 | | tax credit/rebate |
Medimmune Oncology, Inc. | AstraZeneca | Maryland | state | 2004 | $103,579 | | tax credit/rebate |
Medimmune Oncology, Inc. | AstraZeneca | Maryland | state | 2007 | $36,938 | | tax credit/rebate |
MedImmune LLC | AstraZeneca | Maryland | state | 2015 | $1,500,000 | | grant/loan hybrid program |
MedImmune LLC | AstraZeneca | Maryland | state | 2021 | $794,270 | | tax credit/rebate |
MedImmune Inc. | AstraZeneca | Maryland | state | 2006 | $7,500,000 | | grant/loan hybrid program |
MEDICIS THE DERMATOLOGY CO | Bausch Health | California | local | 2012 | undisclosed | | tax credit/rebate |
MEDICIS TECHNOLOGIES CORPORATION | Bausch Health | Washington | state | 2004 | undisclosed | | tax credit/rebate |
MEDICIS TECHNOLOGIES CORPORATION | Bausch Health | Washington | state | 2005 | undisclosed | | tax credit/rebate |
MEDICIS TECHNOLOGIES CORPORATION | Bausch Health | Washington | state | 2008 | undisclosed | | tax credit/rebate |